Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-26T05:29:23.063Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment Considerations for Depression in the Elderly

Published online by Cambridge University Press:  07 November 2014

David L. Dunner
Get access Rights & Permissions [Opens in a new window]

Abstract

While an episode of depression can first present in late life, it is more likely to be a recurrence of a disorder that began earlier in life or a continuation of a chronic form of depression. Depression in the elderly often occurs in the context of ongoing medical conditions. The treatment for these medical conditions may pose problems in treatment of depression due to increased likelihood of drug interactions. This article discusses pharmacotherapeutic and psychotherapeutic approaches to the treatment of depression in the elderly population.

Type
Academic Supplement
Information
CNS Spectrums , Volume 8 , Issue S3: Anxiety and Depression in the Elderly: Implications for Diagnosis and Treatment , December 2003 , pp. 14 - 19
Copyright
Copyright © Cambridge University Press 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Alexopoulos, GS, Katz, IR, Reynolds, CF III, et al.The expert consensus guideline series: pharmacotherapy of depressive disorders in older patients. Postgrad Med. October 2001:1–86. Special Report.Google Scholar
2.Krishnan, KRR, Hays, JC, Tupler, LA, et al.Clinical and phenomenological comparisons of late-onset and early-onset depression. Am J Psychiatry. 1995;152:785–788.Google ScholarPubMed
3.Steffens, DC, Skoog, I, Norton, MC, et al.Prevalence of depression and its treatment in an elderly population: the Cache County Study. Arch Gen Psychiatry. 2000;57:601–607.CrossRefGoogle Scholar
4.Luber, MP, Meyers, BS, Williams-Russo, PG, et al.Depression and service utilization in elderly primary care patients. Am J Geriatr Psychiatry. 2001;9:169–176.CrossRefGoogle ScholarPubMed
5.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.Google Scholar
6.Lenze, EJ. Comorbidity of depression and anxiety in the elderly. Curr Psychiatry Rep. 2003;5:62–67.CrossRefGoogle ScholarPubMed
7.Alexopoulos, GS, Borson, S, Cuthbert, BM, et al.Assessment of late life depression. Biol Psychiatry. 2002;52;164–174.CrossRefGoogle ScholarPubMed
8.Conwell, Y, Duberstein, PR, Caine, ED. Risk factors for suicide in late life. Biol Psychiatry. 2002;52:193–204.CrossRefGoogle Scholar
9.Hirschfeld, RMA, Russell, JM. Assessment and treatment of suicidal patients. N Eng J Med. 1997;337:910–915.CrossRefGoogle ScholarPubMed
10.Szanto, K, Mulsant, BH, Houck, P, et al.Occurrence and course of suicidality during short-term treatment of late-life depression. Arch Gen Psychiatry. 2003;60:610–617.CrossRefGoogle ScholarPubMed
11.Krishnan, KRR. Biological risk factors in late depression. Biol Psychiatry. 2002;52:185–192.CrossRefGoogle Scholar
12.Whyte, EM, Mulsant, BH. Post stroke depression: epidemiology, psychopathology, and biological treatment. Biol Psychiatry. 2002;52:253–264.CrossRefGoogle Scholar
13.Devanand, DP. Comorbid psychiatric disorders in late life depression. Biol Psychiatry. 2002;52:236–242.CrossRefGoogle ScholarPubMed
14.Krishnan, KR, Hays, JC, Blazer, DG. MRI-defined vascular depression. Am J Psychiatry. 1997;154:497–501.Google ScholarPubMed
15.Robinson, RG, Schultz, SK, Castillo, C, et al.Nortriptyline versus fluoxetine in the treatment of depression and in short term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry. 2000;157:351–359.CrossRefGoogle ScholarPubMed
16.Alexopoulos, GS, Kiosses, DN, Choi, SJ, et al.Frontal white matter microstructure and treatment response of late-life depression: a preliminary study. Am J Psychiatry. 2002;159:1929–1932.CrossRefGoogle ScholarPubMed
17.Miller, MD, Lenze, EJ, Dew, MA, et al.Effect of cerebrovascular risk factors in depression treatment outcome in later life. Am J Psychiatry. 2002;10:592–598.Google ScholarPubMed
18.Salloway, S, Boyle, PA, Correia, S, et al.The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed out-patients. Am J Psychiatry. 2002;10:107–111.Google Scholar
19.Bruce, ML. Psychosocial risk factors for depressive disorders in late life. Biol Psychiatry. 2002;52:175–184.CrossRefGoogle ScholarPubMed
20.Arean, PA, Cook, BL. Psychotherapy and combined psychotherapy/pharmacology for late life depression. Biol Psychiatry. 2002;52:293–303.CrossRefGoogle Scholar
21.Gallagher-Thompson, D, Hanley-Peterson, P, Thompson, LW. Maintenance of gains versus relapse following brief psychotherapy for depression. J Consult Clin Psychol. 1990;58:371–374.CrossRefGoogle ScholarPubMed
22.Reynolds, CF III, Frank, E, Perel, JM, et al.Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA. 1999;281:39–45.CrossRefGoogle ScholarPubMed
23.Lenze, EJ, Dew, MA, Mazumdar, S, et al.Combined pharmacotherapy and psychotherapy as maintenance treatment for late-life depression: effects of social adjustment. Am J Psychiatry. 2002;159:466–468.CrossRefGoogle ScholarPubMed
24.Unützer, J, Katon, W, Callahan, CM, et al.Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288:2836–2845.CrossRefGoogle ScholarPubMed
25.Salzman, C, Wong, E, Wright, BC. Drug and ECT treatment of depression in the elderly, 1996-2001: a literature review. Biol Psychiatry. 2002;52:265–284.CrossRefGoogle ScholarPubMed
26.Kirby, D, Harrigan, S, Ames, D. Hyponatremia in elderly psychiatric patients treated with selective serotonin reuptake inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit. Int J Geriatric Psychiatry. 2002;17:231–237.CrossRefGoogle Scholar
27.Heiligenstein, JH, Ware, JE, Buesterien, KM, et al.Acute effects of fluoxetine versus placebo on functional health and well-being in late-life depression. Int Psychogeriatr. 1995;7(suppl):125–137.CrossRefGoogle ScholarPubMed
28.Small, GW, Hamilton, SH, Bystritsky, A, et al.Clinical response predictors in a double-blind, placebo-controlled trial of fluoxetine for geriatric major depression. Fluoxetine Collaborative Study Group. Int Psychogeriatr. 1995;7(suppl):41–53.CrossRefGoogle Scholar
29.Koran, LM, Hamilton, SH, Hertzman, M, et al.Predicting response to fluoxetine in geriatric patients with major depression. J Clin Psychopharmacol. 1995;15:421–427.CrossRefGoogle ScholarPubMed
30.Arranz, FJ, Ros, S. Effects of comorbidity and polypharmacy in the clinical usefulness of sertraline in elderly depressed patients: an open multicenter study. J Affect Disor. 1997;46:285–291.CrossRefGoogle Scholar
31.Schneider, LS, Nelson, JC, Clary, CM, et al.An 8-week multicenter, parallel group, double-blind, placebo-controlled study of sertraline in elderly patients with major depression. Am J Psychiatry. 2003;160:1277–1285.CrossRefGoogle ScholarPubMed
32.Bump, GM, Mulsant, BH, Pollock, MG, et al.Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly. Depress Anxiety. 2001;13:38–44.3.0.CO;2-7>CrossRefGoogle ScholarPubMed
33.Mulsant, BH, Pollock, BG, Nebes, RD, et al.A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6 week outcome. J Clin Psychiatry. 1999;60(suppl 20):16–20.Google ScholarPubMed
34.Dunner, DL, Cohn, JB, Walshe, T III, et al.Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. J Clin Psychiatry. 1992;53(suppl):57–60.Google ScholarPubMed
35.Reynolds, CF III. Paroxetine treatment of depression of late life. Psychopharm Bull. 2003;37(suppl):123–134.Google ScholarPubMed
36.Rapaport, MH, Schneider, LS, Dunner, DL, et al.Efficacy of controlled-release paroxetine in the treatment of late-life depression. J Clin Psychiatry. 2003;64:1065–1074.CrossRefGoogle ScholarPubMed
37.Karlsson, I, Godderis, K, De Mendonca, A, Lima, C. A randomized, double-blind comparison of the efficacy and safety of citalopram combined with mianserin in elderly, depressed patients with or without mild to moderate dementia. Int J Clin Psychiatry. 2000;15:295–305.Google ScholarPubMed
38.Kyle, CJ, Peterson, HEH, Overo, KF. Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice. Depress Anxiety. 1998;8:147–153.3.0.CO;2-F>CrossRefGoogle ScholarPubMed
39.Altamura, AC, Mauri, MC, Rudas, N, et al.Clinical activity and tolerability of trazodone, mianserin, and amitriptyline in elderly subjects with major depression: a controlled multicenter trial. Clin Neuropharmacol. 1989;12(suppl 1):S25–S37.CrossRefGoogle ScholarPubMed
40.Scher, M, Krieger, JN, Juergens, S. Trazodone and priapism. Am J Psychiatry. 1983;140:1362–1363.Google ScholarPubMed
41.Weihs, KL, Settle, EC Jr, Batey, SR, et al.Bupropion sustained release versus paroxetine for the treatment of depression in the elderly. J Clin Psychiatry. 2000;61:196–202.CrossRefGoogle ScholarPubMed
42.Steffens, DC, Doraiswamy, PM, McQuoid, DR. Bupropion SR in the naturalistic treatment of elderly patients with major depression. Int J Geriatr Psychiatry. 2001;16:862–865.CrossRefGoogle ScholarPubMed
43. Wellbutrin (package insert). Research Triangle Park, NC: GlaxoSmithKline; 2001.Google Scholar
44.Amore, M, Ricci, M, Zanardi, R, et al.Long-term treatment of geropsychiatric depressed patients with venlafaxine. J Affect Disord. 1997;46:293–296.CrossRefGoogle ScholarPubMed
45.Dierick, M. An open-label evaluation of the long-term safety of oral venlafaxine in depressed elderly patients. Ann Clin Psychiatry. 1996;8:169–178.CrossRefGoogle ScholarPubMed
46.Khan, A, Rudolph, R, Baumel, B, et al.Venlafaxine in depressed geriatric outpatients: an open-label clinical study. Psychopharm Bull. 1995;31:753–758.Google ScholarPubMed
47.Mahaptra, SN. A randomized, double-blind, parallel group comparison of venlafaxine and dothiepin in geriatric patients with major depression. IJPC. 1997;51:209–213.Google Scholar
48.Staab, JP, Evans, DL. Efficacy of venlafaxine in geriatric depression. Depress Anxiety. 2000;12(suppl 1):63–68.3.0.CO;2-T>CrossRefGoogle ScholarPubMed
49.Goldberg, RJ. Antidepressant use in the elderly: current status of nefazodone, venlafaxine, and moclobemide. Drugs Aging. 1997;11:119–131.CrossRefGoogle ScholarPubMed
50.Thase, ME, Entsuah, AR, Rudolph, RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry. 2001;178:234–241.CrossRefGoogle ScholarPubMed
51.Keller, MB, McCullough, JP, Klein, DN, et al.A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. NEJM. 2000;342:1462–1470.CrossRefGoogle ScholarPubMed
52.Dunner, DL, Laird, LK. Comparative safety and tolerability of nefazodone. J Clin Psychiatry. 2003;63(suppl 1):33–36.Google Scholar
53.Hoyberg, OJ, Maragakis, B, Mullin, J, et al.A double-blind multicenter comparison of mirtazapine and amitriptyline in elderly depressed patients. Acta Psychiatr Scand. 1996;93:184–190.Google ScholarPubMed
54.Schatzberg, AF, Kremer, C, Rodrigues, HE, et al.Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. Am J Geriatr Psychiatry. 2002;10:541–550.CrossRefGoogle ScholarPubMed
55.Abrams, R. Electroconvulsive Therapy. 4th ed. New York, NY: Oxford Press; 2002.CrossRefGoogle ScholarPubMed
56.Small, JG, Kellams, JJ, Milstein, , et al.Complications with electroconvulsive treatment combined with lithium. Biol Psychiatry. 1980;15:103–112.Google ScholarPubMed